Benitec Biopharma (BNTC) Assets (2019 - 2025)
Benitec Biopharma (BNTC) posted Assets of $190.7 million for Q4 2025, up 98.57% sequentially from $96.0 million in Q3 2025, and up 141.16% YoY from $79.1 million in Q4 2024.
Benitec Biopharma (BNTC) Assets (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Assets for 7 years, with the latest figure at $190.7 million in Q4 2025.
- Quarterly Assets rose 141.16% year-over-year to $190.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $190.7 million (up 141.16% YoY) and the FY2025 annual result came in at $99.6 million, up 90.75% from the prior year.
- Assets advanced to $190.7 million in Q4 2025 per BNTC's latest filing, from $96.0 million in the prior quarter.
- Over five years, Assets peaked at $190.7 million in Q4 2025 and troughed at $4.5 million in Q2 2023.
- A 5-year average of $40.8 million and a median of $18.1 million in 2022 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2024: Assets slumped 72.06% in 2022, then surged 1069.58% in 2024.
- Over 5 years, Assets stood at $14.0 million in 2021, then declined by 15.05% to $11.9 million in 2022, then surged by 79.36% to $21.4 million in 2023, then jumped by 270.29% to $79.1 million in 2024, then soared by 141.16% to $190.7 million in 2025.
- According to Business Quant data, Assets over the past three periods registered $190.7 million, $96.0 million, and $99.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | 190.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 190.68 Mn |
| Sep 30, 2025 | 96.03 Mn |
| Jun 30, 2025 | 99.59 Mn |
| Dec 31, 2024 | 79.07 Mn |
| Sep 30, 2024 | 68.77 Mn |
| Jun 30, 2024 | 52.21 Mn |
| Mar 31, 2024 | 15.00 Mn |
| Dec 31, 2023 | 21.35 Mn |
| Sep 30, 2023 | 27.05 Mn |
| Jun 30, 2023 | 4.46 Mn |
| Mar 31, 2023 | 8.22 Mn |
| Dec 31, 2022 | 11.91 Mn |
| Sep 30, 2022 | 18.12 Mn |
| Jun 30, 2022 | 5.97 Mn |
| Mar 31, 2022 | 10.06 Mn |
| Dec 31, 2021 | 14.01 Mn |
| Sep 30, 2021 | 17.84 Mn |
| Jun 30, 2021 | 21.38 Mn |
| Mar 31, 2021 | 13.43 Mn |
| Dec 31, 2020 | 15.51 Mn |